News
Novo Nordisk gør det klart, at medicinalgiganten vil samarbejde med Det Europæiske Lægemiddelagentur, når det gælder ...
Helgi Kormaksson Joins CTS Executive Team SAN FRANCISCO, CA / ACCESS Newswire / June 6, 2025 / CTS is excited to announce that Helgi Kormaksson has joined the company as Chief Design Officer. Helgi ...
Weight-loss drugs are already dropping in price; could they go even lower? - Consumers are now able to pay roughly $500 for ...
Novo Nordisk vil bygge kilometer langt hegn rundt om virksomhedens faciliteter i Hillerød. Det skriver den danske medicinalvirksomhed til Sjællandske Nyheder.
Medicinalgiganten Novo Nordisk afviser, at der er en sammenhæng mellem behandling med slankemidlet Wegovy og øjensygdommen ...
Zacks Investment Research on MSN7h
Is Novo Nordisk's Next Generation Obesity Pipeline a Game Changer?Novo Nordisk NVO has seen strong momentum in recent years, driven by the commercial success of its blockbuster semaglutide ...
Human insulin presents Indian companies an opportunity estimated at Rs 450 crore per annum in India and $157 million/annum in ...
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.
Der er 33 analytikere, som følger Novo -aktien indgående. Det samlede billede viser, at 20 analytikerne anbefaler investorer ...
I've been a Novo Nordisk bull for quite some time now, and I wouldn't be as spooked by the situation. Here's why. Novo Nordisk got a two-year-plus head start in the white-hot obesity drugs market, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback